手機(jī)掃碼訪問(wèn)本站
微信咨詢
猜你喜歡
- 2-(全氟癸基)乙基甲基丙烯酸酯
- 104987-11-3/他克莫司的臨床應(yīng)用是什么
- 2-乙基己酸鎂
- 4-CHLORO-3-(TRIFLUOROMETHYL)-5-(PHENYL)PYRAZOLE
- 3-(2-甲氧基乙基)苯酚
- 2-氨基-3-羥甲基吡啶
- ETHYL 4-OXO-4-[2-(3-PYRROLINOMETHYL)PHENYL]BUTYRATE
- DesMethyl AMidosulfuron
- 3-甲酰基-6-甲基色酮
- 4-溴-5-(1-吡咯烷基)-3(2H)-噠嗪酮
- 苯甲酮-2,4,5-三羧酸
- (1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID ALLYL ESTER
- N-(E)-3-TRIBUTYLTINALLYL-1-NAPHTHALENE-D7-METHYLAMINE
- 5-(2,4二-氯苯甲基硫代)-2-巰基-1,3,4-噻二唑
- 六甲基二硅烷
- R-(-)-N-DESMETHYLMEPHENYTOIN
- 4-Pyridinecarbonyl chloride, 3-methyl- (9CI)
- (1S,2S,4S)-BICYCLO[2.2.1]HEPT-5-EN-2-YLACETIC ACID
- 己烯雌酚
- 2,5-DICHLORO-4′-(3-PYRROLINOMETHYL) BENZOPHENONE
- 四氟苯菊酯
- 99-76-3 / 尼泊金甲酯的應(yīng)用及安全性
- 2-苯基-2-乙基丁酸
- 單過(guò)氧鄰苯二甲酸鎂六水合物
- 224785-91-5 / 伐地那非首仿獲批在即，科倫有望入圍PDE-5抑制劑市場(chǎng)
